Your AI-Trained Oncology Knowledge Connection!
Opinion
Video
Author(s):
The panel reviews recent data on MRD testing in colorectal cancer, highlighting the INTERCEPT and COSMOS-CRC-01 studies.
Stay up to date on the most recent and practice-changing oncology data
Comprehensive Communication Regarding CRC Surgery and Postoperative Complications Is Crucial
FDA Approval Insights: Sotorasib Plus Panitumumab for KRAS G12C–Mutated mCRC: With Marwan Fakih, MD
Five Under 5: Top Oncology Videos for the Week of 3/9
Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD
HER2+ Early Breast Cancer: Tailoring Therapy in the Era of Expanding Options
Cell-Free DNA Blood-Based Assay Is Not Superior to Colonoscopy in Colorectal Cancer
First-Line Atezolizumab Is Suitable in Platinum-Based Chemotherapy Ineligible mUC
Adjuvant CDK4/6 Inhibitors Lay a Solid Treatment Foundation in HR+, HER2– Breast Cancer
Ocular AEs From Mirvetuximab Soravtansine Do Not Impact HRQOL in FRα+ Platinum-Resistant Ovarian Cancer
Abemaciclib/Hormonal Therapy Combo Yields Clinical Activity in LGSOC/EEC